ClearPoint Neuro, Inc. (CLPT) Return on equity 2017–2025
ClearPoint Neuro, Inc. (CLPT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-91.1%FY2025 · since FY2017: -123.0% → -91.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -91.1% | -16.7 pp |
| FY2024 | -74.5% | +29.8 pp |
| FY2023 | -104.3% | -59.8 pp |
| FY2022 | -44.6% | -15.0 pp |
| FY2021 | -29.5% | +255.8 pp |
| FY2020 | -285.3% | -164.5 pp |
| FY2019 | -120.8% | +287.4 pp |
| FY2018 | -408.2% | -285.2 pp |
| FY2017 | -123.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CLPT financial trends
CLPT RevenueCLPT Net incomeCLPT Net marginCLPT Gross profitCLPT Gross marginCLPT Operating incomeCLPT Operating marginCLPT Operating cash flowCLPT Free cash flowCLPT Capital expendituresCLPT Stock buybacksCLPT Dividends paidCLPT Total assetsCLPT Total liabilitiesCLPT Shareholders’ equityCLPT overview →